We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$774M
AUM Growth
+$32M
Cap. Flow
+$4.48M
Cap. Flow %
0.58%
Top 10 Hldgs %
60.49%
Holding
103
New
9
Increased
21
Reduced
5
Closed
13

Sector Composition

Rank Sector Weight
1 Financials 39.59%
2 Healthcare 25.46%
3 Technology 10.29%
4 Industrials 10.13%
5 Energy 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAI
101
DELISTED
Reynolds American Inc
RAI
-3,080
Closed -$200K

Similar funds

Hikari Power's Q3 2017 Portfolio in Review

As of Q3 2017, Hikari Power held 103 positions worth $774M, up 4.3% from $741M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power's Q3 2017 filing shows 9 new, 21 increased, 5 reduced and 13 closed positions. Its largest new stake was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M. The largest sale was Stericycle Inc, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Technology.

  • Hikari Power's largest Q3 2017 buy was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M.
  • Hikari Power added most to Synergy Pharmaceuticals, Inc Common Stock in Q3 2017, an estimated $3.41M increase.
  • Hikari Power's biggest Q3 2017 reduction was Stericycle Inc, cutting an estimated $6.93M.
  • Hikari Power fully exited Opko Health in Q3 2017, selling an estimated $917K.
  • Hikari Power's ten largest holdings make up 60% of its $774M portfolio in Q3 2017.
  • Hikari Power opened 9 new positions and closed 13 in Q3 2017.
  • Hikari Power's portfolio value rose 4.3% quarter-over-quarter to $774M.

Based on Hikari Power's 13F filing for Q3 2017, filed 8 Nov 2017.